Strategy for RMG1
I seek to exploit inefficiencies that exist in the buy/sell side research models for maximum benefit. The greatest gaps in investment coverage appear to exist in global companies, both large and small. I look to own emerging growth companies while paying no more than value prices.
For RMG1, I primarily own larger companies throughout the world featuring strong balance sheets, in investor friendly jurisdictions, that demonstrate accelerating EBITDA growth.
Companies reviewed should meet the following criteria:
- Firms should sell for a healthy discount to their peer group on a forward EV/EBITDA basis. I prefer to own stocks which sell for 10X forward EVEBITDA or less.
- The company must generate sufficient free cash flow to maintain and grow the business by a minimum 10% per year, without requiring financing. This degree of self sufficiency suggests that conventional investment coverage may be limited or possibly non existent.
- Barriers to entry should be sizeable in the industry that the company operates in. I greatly prefer to own businesses that have monopoly or oligopoly characteristics.
- Close attention is paid to owning stocks which have experienced a catalyst that should increase EBITDA sharply. The positive catalyst also generally results in improved investment coverage, when sufficient time has passed for analysts to get a handle on the company.
